THB Asset Management’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-1,852
Closed -$3.18M 204
2015
Q3
$3.18M Sell
1,852
-2,325
-56% -$5.61M 0.31% 115
2015
Q2
$11.3M Sell
4,177
-73
-2% -$190K 0.86% 28
2015
Q1
$12.3M Sell
4,250
-516
-11% -$1.43M 0.86% 23
2014
Q4
$12.5M Buy
4,766
+290
+6% +$750K 0.83% 27
2014
Q3
$12.3M Buy
4,476
+1,028
+30% +$3.34M 0.85% 23
2014
Q2
$11.9M Buy
3,448
+926
+37% +$3.29M 0.74% 39
2014
Q1
$9.17M Buy
2,522
+1,123
+80% +$4.42M 0.55% 73
2013
Q4
$5.27M Buy
1,399
+238
+20% +$857K 0.29% 140
2013
Q3
$3.79M Buy
+1,161
New +$3.4M 0.24% 156

Other funds holding TRIB

THB Asset Management's TRIB Position: Q4 2015 in Review

THB Asset Management sold out of Trinity Biotech (TRIB) in Q4 2015, closing a stake of 1,852 shares — an estimated $3.18M sold.

THB Asset Management first reported a position in TRIB in Q3 2013 and held it in 9 quarters. The position peaked at $12.5M in Q4 2014. 81 funds tracked by Wall St. Rank hold TRIB as of Q4 2015.

  • THB Asset Management reported no remaining Trinity Biotech position as of Q4 2015 after selling out during the quarter.
  • THB Asset Management sold 1,852 Trinity Biotech shares in Q4 2015, an estimated $3.18M.
  • THB Asset Management first reported a position in Trinity Biotech in Q3 2013 and held it in 9 quarters.
  • THB Asset Management's Trinity Biotech position peaked at $12.5M in Q4 2014.
  • 81 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2015.

Based on THB Asset Management's 13F filing for Q4 2015, filed 12 Jan 2016.